University of Maryland, Department of Pharmaceutical Sciences, 20 Penn Street, Baltimore, MD 21201, USA; University of Health Sciences, Gulhane Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Turkey.
University of Maryland, Department of Pharmaceutical Sciences, 20 Penn Street, Baltimore, MD 21201, USA.
Int J Pharm. 2022 Aug 25;624:122015. doi: 10.1016/j.ijpharm.2022.122015. Epub 2022 Jul 15.
Etravirine is an antiviral whose oral absorption is limited by low solubility/dissolution. The objective was to predict and compare etravirine's surfactant-mediated dissolution into polyoxyethylene-10 lauryl ether (POE) and FeSSIF-V2, including the contribution of slow micelle diffusivity. Dynamic light scattering (DLS) was used to measure the size and diffusivity values of drug-loaded micelles. In vitro intrinsic dissolution into surfactant media were predicted using a model for surfactant-mediated dissolution. Compared to maleic buffer, POE and FeSSIF-V2 increased etravirine solubility 232-fold and 8.97-fold, respectively. From DLS, micelle diffusivity of drug-loaded POE micelle and FeSSIF-V2 mixed-micelle was 5.15x10 cm/s and 5.76x10 cm/s, respectively. Observed and predicted dissolution enhancement into POE were 50.7 and 31.3, and 1.26 and 1.24 into FeSSIF-V2, respectively. Hence, there was high dissolution enhancement into POE, although the observed enhancement was only 21.9% of the observed solubility enhancement, reflecting the attenuating impact of the large and slowly diffusing drug-loaded POE micelles. Meanwhile, there was minimal dissolution enhancement into FeSSIF-V2, and the observed enhancement was only 14.0% of the observed solubility enhancement, reflecting the even slower diffusing drug-loaded FeSSIF-V2 mixed-micelles compared to drug-loaded POE micelles. Results are considered in light of designing a single pharmaceutical surfactant system for dissolution that mimics a FeSSIF-V2 system.
依曲韦林是一种抗病毒药物,其口服吸收受到低溶解度/溶解的限制。目的是预测和比较依曲韦林在聚氧乙烯-10 月桂醚(POE)和 FeSSIF-V2 中的表面活性剂介导的溶解情况,包括慢胶束扩散的贡献。动态光散射(DLS)用于测量载药胶束的大小和扩散值。使用表面活性剂介导溶解模型预测药物在表面活性剂介质中的内在溶解。与马来酸缓冲液相比,POE 和 FeSSIF-V2 分别将依曲韦林的溶解度提高了 232 倍和 8.97 倍。从 DLS 来看,载药 POE 胶束和 FeSSIF-V2 混合胶束的胶束扩散率分别为 5.15x10 cm/s 和 5.76x10 cm/s。观察到的和预测的 POE 中的溶解增强分别为 50.7 和 31.3,进入 FeSSIF-V2 中的分别为 1.26 和 1.24。因此,POE 中的溶解增强很高,尽管观察到的增强仅为观察到的溶解度增强的 21.9%,反映了大且扩散缓慢的载药 POE 胶束的衰减影响。同时,进入 FeSSIF-V2 的溶解增强很小,观察到的增强仅为观察到的溶解度增强的 14.0%,这反映了与载药 POE 胶束相比,载药 FeSSIF-V2 混合胶束的扩散更慢。结果考虑了设计一种模仿 FeSSIF-V2 系统的单一药物表面活性剂系统来溶解的问题。